Patent details

301159 Product Name: bimekizumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301159
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2663577
Status:
SPC granted but not yet in force
Application number:
301159
Procedural language:
Dutch
First Applicant Residence Country:
Belgium (BE)

Marketing Authorization

Marketing Authorization Number:
EU/1/21/1575
Marketing Authorization Type:
EEA
Marketing Authorization Date:
23/08/2021
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
19/01/2022
First Marketing Authorization date:
23/08/2021
Grant date:
10/02/2022
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
19/01/2022
SPC/SPC Extension Expiration Date:
22/08/2036
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
19/01/2022
 
 

 

Name:
UCB Biopharma SRL
Address:
Allée de la Recherche 60, 1070, Brussels, Belgium (BE)

Agent

Name:
ir. B.Ch. Ledeboer c.s
From:
19/01/2022
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
07/22
Publication date:
16/02/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
04/22
Publication date:
26/01/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/01/2032
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
10/02/2022 Outgoing Correspondence Decision grant 1 PDF /4/0/7/2/6/0800762704/docs/301159_5_461835l504a.pdf
10/02/2022 Certificate Certificate 1 PDF /4/0/7/2/6/0800762704/docs/301159_6_spcmedcertificate20220210093516129.pdf
19/01/2022 SPC Documents Annex SPC 3 PDF /4/0/7/2/6/0800762704/docs/301159_0_supplprotectioncertificate20220119022939474.pdf
19/01/2022 SPC Documents SPC Documents 3 PDF /4/0/7/2/6/0800762704/docs/301159_1_supplprotectioncertificate20220119022939436.pdf
19/01/2022 Outgoing Correspondence Confirmation receipt request 1 PDF /4/0/7/2/6/0800762704/docs/301159_2_457091l174.pdf
19/01/2022 SPC Documents Annex SPC 3 PDF /4/0/7/2/6/0800762704/docs/301159_3_supplprotectioncertificate20220119022939517.pdf
19/01/2022 Application Form First filed application form 3 PDF /4/0/7/2/6/0800762704/docs/301159_4_applicationform20220119022939364.pdf
19/01/2022 SPC Documents Annex SPC 37 PDF /4/0/7/2/6/0800762704/docs/301159_7_supplprotectioncertificate20220119022939490.pdf
19/01/2022 SPC Documents Summary of the characteristics of the product 17 PDF /4/0/7/2/6/0800762704/docs/301159_8_supplprotectioncertificate20220119031402875.pdf
19/01/2022 SPC Documents Accompanying letter SPC 4 PDF /4/0/7/2/6/0800762704/docs/301159_9_supplprotectioncertificate20220119031224015.pdf